Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.01 (-1.40%)
Close on Nov 18, 2026Market cap $1.27MP/E –Yield –
Scinai Immunotherapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Scinai Immunotherapeutics's enterprise value was $247.41K on Nov 11, 2026, against $14.61M a year earlier. Over the last 5 years it ranged from $34.23K to $289.56M, with a median of $24.12M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $247.41K | -97.5% |
| 2025 | Dec 31, 2025 | $9.79M | -60.7% |
| 2024 | Dec 31, 2024 | $24.93M | +76.4% |
| 2023 | Dec 29, 2023 | $14.14M | -53.6% |
| 2022 | Dec 30, 2022 | $30.49M | -87.8% |
| 2021 | Dec 31, 2021 | $249.68M | +20.7% |
| 2020 | Dec 31, 2020 | $206.93M | -65.9% |
| 2019 | Dec 31, 2019 | $607.15M | +177.1% |
| 2018 | Dec 31, 2018 | $219.14M | +24.2% |
| 2017 | Dec 29, 2017 | $176.50M | +99.7% |
| 2016 | Dec 30, 2016 | $88.38M | – |
See a number that looks wrong?